23andMe (ME) - 2024 Q1 - Earnings Call Transcript

23andMe Holding Co. (NASDAQ:ME) Q1 2024 Earnings Conference Call August 8, 2023 4:30 PM ET Company Participants Katie Watson - Vice President of Communications Anne Wojcicki - Chief Executive Officer and Co-Founder Joe Selsavage - Interim Chief Financial and Accounting Officer Kenneth Hillan - Chief Therapeutics Officer Conference Call Participants David Lebowitz - Citi Gaurav Goparaju - Berenberg Capital Markets Operator Hello, and welcome to 23andMe’s Fiscal Year 2024 First Quarter Financial Results Confe ...